Groove Botanicals 3Q 2026: Revenue $0, EPS ($0.00) — 10-Q Summary
Groove Botanicals reported zero revenue and a narrowed net loss of $86,180 for 3Q 2026. Operating expenses increased, but lower SG&A expenses and other income offset higher legal costs. Diluted EPS was ($0.00).
How this was made

The 30-second read
Why it matters
The filing confirms ongoing financial challenges, likely keeping the stock under pressure.
Market read
Primary disclosure of quarterly results for a microcap; limited trading relevance due to small scale.
What to watch
Legal expenses may be one-time; future revenue could improve with product launches.
Background
Groove Botanicals filed its Q3 2026 10-Q, reporting zero revenue and a modest net loss.
Ticker impact
Quarterly 10-Q shows revenue of $0 and a narrowed net loss of $86.18K, with higher legal expenses and lower SG&A.
likely downside as market prices in the continued loss and higher legal costs
Microcap with minimal revenue and a net loss signals limited upside; investors may sell on the negative earnings surprise.
Market effects
Limited impact on broader sector; highlights challenges for early-stage botanical product companies.
No significant regional effect.
Minimal global relevance.
Counterpoint
Potential upside if the company secures future contracts or funding despite current losses.
Key entities
- CompanyGroove Botanicals Inc.
Microcap biotech firm reporting Q3 2026 results.


